|
|
|
Torrent,
Ranbaxy front-runners in race for Kopran’s Aten brand
|
| |
TORRENT
Pharmaceuticals and Ranbaxy Laboratories are believed to be
the front-runners for a strategic deal revolving around the
Mumbai-based Kopran’s Aten brand (an anti-anginal) and/or its
entire formulations business. |
|
|
Reckitt
Benckiser unveils 2 Dispirin versions |
| |
RECKITT
Benckiser, the Indian arm of $5-billion Reckitt Benckiser Plc,
has launched two new versions of its 24-year old brand Dispirin
for various therapeutic uses in a bid to extend the reach of
its Dispirin brand. |
|
|
Roche
offers $20 billion for Bayer drugs unit |
| |
SWISS
healthcare giant Roche Holding AG has approached German rival
Bayer AG with a preliminary proposal to buy its drugs business
for around $20 billion, people familiar with the situation said. |
|
|
Bulk
drug manufacturers oppose differential duty |
| |
INDIAN
bulk drug manufacturers have expressed their dissatisfaction
to the Central Board of Excise and Customs (CBEC) on its demand
for the payment of differential duty on account of DPCO 1987
(which is redundant) and notification 6/94 and 7/94 dated March
1, 1994 for the period of 33 days from 6/1/1995 to 9/2/95. |
|
